Sarah Ford | January 22, 2015
New Treatment Option For Marfan Syndrome
The Winter issue of The Marfan Foundation’s magazine, Connective Issues, is now available.
In this issue, The Marfan Foundation shares extensive research news, including the results of the Atenolol vs. Losartan in Marfan Syndrome clinical trial, conducted by the National Heart, Lung, and Blood Institute’s (NHLBI) Pediatric Heart Network and supported by The Marfan Foundation.
The identification of TGF-beta as a possible factor contributing to the characteristics of Marfan syndrome in 2003 unlocked the doors to scientific discovery in Marfan syndrome. ÌýThe first and largest subsequent initiative was the atenolol vs losartan clinical trial. ÌýIt gave The Marfan Foundation the opportunity to partner with NHLBI, which saw the promise of this breakthrough in Marfan syndrome and was committed to the research. Ìý
The atenolol vs losartan study has spawned multiple studies worldwide and, through The Marfan Foundation’s robust research program, they are playing a leading role in advancing the science.
Read about this latest study, the upcoming March For Marfan, and more.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
February is Marfan Awareness Month!
Marfan syndrome affects an estimated 1 in 5,000 people regardless of race, ethnicity, or gender, and experts estimateÌýthat nearly half the people who have Marfan…
Read Article
February is Cancer Prevention Month
A substantial proportion of cancers could be prevented, including all cancers caused by tobacco use and other unhealthy behaviors. Excluding non-melanoma skin cancer, at least…
Read Article
Celebrating the Agents of Change this Black History Month
During Black History Month, which takes place each year during the month of February, there is much to celebrate about the past achievements and impact…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
